Sort   by:  
 Page size 
Not available
ORGANISM(S): Homo sapiens 
To study the effects of IDH mutations, we collected and performed gene expression microarray analysis with tumor specimens from patients with grade II-III oligodendroglioma. Sequencing for mutations of IDH1 and IDH2 was done. Gene expression was compared between IDH wildtype vs. mutant samples
ORGANISM(S): Homo sapiens 
More than 50% of patients with chondrosarcomas exhibit gain-of-function mutations in either isocitrate dehydrogenase 1 (IDH1) or IDH2. In this study, we performed genome-wide CpG methylation sequencing of chondrosarcoma biopsies and found that IDH mutations were associated with DNA hypermethylation ...
ORGANISM(S): Homo sapiens 
Mutations in isocitrate dehydrogenase 2 (IDH2) occur in many cancers including Acute Myeloid Leukemia (AML). In preclinical models mutant IDH2 causes partial hemopoietic differentiation arrest. Recently, we showed that single agent Enasidenib, a first-in-class, selective mutant IDH2 inhibitor, produ...
ORGANISM(S): Homo sapiens 
Isocitrate Dehydrogenase 1 Primes Group-3 Medulloblastomas For Cuproptosis
Targeting chordoma via an Isocitrate Dehydrogenase-1 dependent susceptibility to redox metabolism
Isoform switching as a mechanism of acquired resistance to isocitrate dehydrogenase inhibition
Genomics
Decifiency of NADP isocitrate dehydrogenase
Astrocytoma, oligodendroglioma, oligoastrocytoma, and ependymoma are the main histologic subtypes of glioma. The molecular character of these subtypes has profound implications for understanding their causes and treatment. We describe the epigenetic landscape of these tumor types using novel DNA met...
ORGANISM(S): Homo sapiens 
Immune landscape of Isocitrate Dehydrogenase (IDH) stratified human gliomas [RNA-Seq]
Sort   by:  
 Page size